Geratam is a brand of piracetam. This product is developed and marketed by UCB, a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB pharma actually discovered piracetam, and piracetam remains one of UCB's key products. Geratam is also sold under the name Nootropil.
This product is not approved by the FDA. It is offered for laboratory research only.